(1/2) Canada has world-class regenerative medicine science, but promising discoveries need support to become Canadian companies and new therapies. SCN CEO @catemurray1.bsky.social and RejuvenRx CEO Anne Marinier discuss that commercialization gap,
innovatingcanada.caBetting on Canada’s Most Innovative Regenerative Medicine StartupsThe Stem Cell Network’s first Incubation Investment Award winner, regenerative medicine biotech company RejuvenRx, receives $1 million to advance its research. Imagine if a pill could reset unhealthy ...
0 reposts0 likes